(+)-Alpha-Dihydrotetrabenazine Phase I
Clinical trial NCT02844179 · COMPLETED
Trial details
- NCT number
- NCT02844179
- Sponsor
- Kirk A. Frey
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2017-06-27
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.